Table 1.
Characteristics of the study population.
| Characteristics | MPP | Control (n = 29) | P-value** | ||||
|---|---|---|---|---|---|---|---|
| Total (n = 158) | MPR (n = 99) | MPA (n = 51) | MPC (n = 8) | P-value* | |||
| Age (years) | 0.52 | 0.0011 | |||||
| Median (interquartile range) | 7.6 (6.0, 9.6) | 8.0 (6.0, 10.0) | 7.3(5.9, 9.0) | 7.8 (7.0, 8.3) | 4.6 (1.0, 10.0) | ||
| Full range | (1.0, 16.0) | (1.0, 16.0) | (1.0, 13.0) | (3.8, 10.0) | (0.2, 13.0) | ||
| Gender | 0.17 | 0.15 | |||||
| Male | 72 (45.6) | 42 (42.4) | 28 (54.9) | 2 (25.0) | 11 (37.9) | ||
| Female | 86 (54.4) | 57 (57.6) | 23 (45.1) | 6 (75.0) | 18 (62.1) | ||
| Severity | 0.51 | — | — | ||||
| Mild | 101 (63.9) | 66 (66.7) | 31 (60.8) | 4 (50.0) | |||
| Severe | 57 (36.1) | 33 (33.3) | 20 (39.2) | 4 (50.0) | |||
| Clinical presentations | |||||||
| Fever | 102 (64.6) | 72 (72.7) | 26 (51.0) | 4 (50.0) | 0.02 | 12 (41.4) | 0.03 |
| Cough | 146 (92.4) | 92 (92.9) | 47 (92.2) | 7 (87.5) | 0.65 | 23 (79.3) | 0.04 |
| Pleural effusion | 46 (29.1) | 8 (28.3) | 16 (31.4) | 2 (25.0) | 0.91 | 3 (10.3) | 0.06 |
| Pulmonary atelectasis | 18 (11.4) | 10 (10.1) | 5 (9.8) | 3 (37.5) | 0.09 | 6 (20.7) | 0.22 |
| Necrotizing pneumonia | 9 (5.7) | 2 (2.0) | 5 (9.8) | 2 (25.0) | 0.01 | 1 (3.4) | 1 |
| Respiratory distress | 1 (0.6) | 0 (0.0) | 1 (2.0) | 0 (0.0) | 0.37 | 2 (6.9) | 0.06 |
| C-reactive protein elevated | 28 (17.7) | 18 (15.2) | 8 (15.7) | 2 (25.0) | 0.77 | 4 (13.8) | 0.79 |
| Dysfunction of blood coagulation | 134 (84.8) | 85 (85.9) | 44 (86.3) | 5 (62.5) | 0.20 | 15 (51.7) | <0.001 |
| Hepatic Insufficiency† | 22 (13.9) | 17 (17.2) | 4 (7.8) | 1 (12.5) | 0.25 | 3 (10.3) | 0.77 |
| Myocardial damage‡ | 11 (7.0) | 9 (9.1) | 2 (3.9) | 0 (0.0) | 0.46 | 5 (17.2) | 0.08 |
*P-values for comparison between MPP subgroups; **P-values for comparison between MPP and Control groups;
†
Hepatic insufficiency, liver damage, and hepatic dysfunction;
‡
Myocardial damage, and electrocardiographic changes associated with myocardial damage.